Sonora Investment Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sonora Investment Management Group's BMY Position: Q2 2025 in Review
Sonora Investment Management Group sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,647 shares — an estimated $283K sold.
Sonora Investment Management Group first reported a position in BMY in Q4 2021 and held it in 14 quarters. The position peaked at $558K in Q3 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Sonora Investment Management Group reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- Sonora Investment Management Group sold 4,647 Bristol-Myers Squibb shares in Q2 2025, an estimated $283K.
- Sonora Investment Management Group first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 14 quarters.
- Sonora Investment Management Group's Bristol-Myers Squibb position peaked at $558K in Q3 2022.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Sonora Investment Management Group's 13F filing for Q2 2025, filed 17 Jul 2025.